A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)

Summary

The purpose of the study is to evaluate the safety and tolerability, the pharmacokinetics and the efficacy of radiprodil in abolishing clinical spasms in subjects with drug-resistant infantile spasms

Timeline

Start

2017-12-04

Primary completion

2018-10-02

Completion

2018-10-02

Outcome

Outcome not reported

Stopped: “After reviewing the feasibility and projected completion date of the study, UCB has made the decision to stop the study”

Drugs

Indications